Production (Stage)
PharmaTher Holdings Ltd.
PHRM
CNSX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 895.20K | 1.11M | 1.41M | 1.69M | 1.91M |
| Total Receivables | 11.10K | 16.80K | 38.00K | 17.20K | 37.20K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 100.00 | 5.60K | 11.10K | 16.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 906.30K | 1.13M | 1.45M | 1.71M | 1.97M |
|
|
|||||
| Total Current Assets | 906.30K | 1.13M | 1.45M | 1.71M | 1.97M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.05M | 1.29M | 1.63M | 1.90M | 2.15M |
|
|
|||||
| Total Accounts Payable | 201.20K | 151.00K | 176.10K | 178.90K | 181.40K |
| Total Accrued Expenses | 6.90K | 8.10K | 6.00K | 6.40K | 4.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 208.10K | 159.10K | 182.10K | 185.40K | 185.50K |
|
|
|||||
| Total Current Liabilities | 208.10K | 159.10K | 182.10K | 185.40K | 185.50K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 208.10K | 159.10K | 182.10K | 185.40K | 185.50K |
|
|
|||||
| Common Stock & APIC | 6.27M | 6.46M | 6.71M | 6.63M | 6.64M |
| Retained Earnings | -8.28M | -8.26M | -8.31M | -7.94M | -7.71M |
| Treasury Stock & Other | 2.85M | 2.94M | 3.05M | 3.02M | 3.03M |
| Total Common Equity | 845.10K | 1.13M | 1.45M | 1.71M | 1.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 845.10K | 1.13M | 1.45M | 1.71M | 1.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 845.10K | 1.13M | 1.45M | 1.71M | 1.96M |
|
|
|||||